How are WVE long put max profit and max loss calculated?

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the WVE long put priced from the end-of-day chain at a 30-day expiry (ATM IV 297.70%), the computed maximum profit is $546.50 per contract and the computed maximum loss is -$52.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a WVE long put?

The breakeven for the WVE long put priced on this page is roughly $5.48 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current WVE market-implied 1-standard-deviation expected move is approximately 85.35%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current WVE implied volatility affect this long put?

WVE ATM IV is at 297.70% with IV rank near 89.48%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.

WVE Long Put Strategy

WVE (Wave Life Sciences Ltd.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company’s medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-008, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of liver disease; WVE-N531, an exon splicing oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington’s disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.

WVE (Wave Life Sciences Ltd.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.12B, a beta of -1.33 versus the broader market, a 52-week range of 5.02-21.73, average daily share volume of 4.0M, a public-listing history dating back to 2015, approximately 317 full-time employees. These structural characteristics shape how WVE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of -1.33 indicates WVE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long put on WVE?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current WVE snapshot

As of June 30, 2026, spot at $5.79, ATM IV 297.70%, IV rank 89.48%, expected move 85.35%. The long put on WVE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this long put structure on WVE specifically: WVE IV at 297.70% is rich versus its 1-year range, which makes a premium-buying WVE long put relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 85.35% (roughly $4.94 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated WVE expiries trade a higher absolute premium for lower per-day decay. Position sizing on WVE should anchor to the underlying notional of $5.79 per share and to the trader's directional view on WVE stock.

WVE long put setup

The WVE long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With WVE near $5.79, the first option leg uses a $6.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed WVE chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 WVE shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Put	$6.00	$0.53

WVE long put risk and reward

Net Premium / Debit: -$52.50
Max Profit (per contract): $546.50
Max Loss (per contract): -$52.50
Breakeven(s): $5.48
Risk / Reward Ratio: 10.410

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

WVE long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on WVE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.8%	+$546.50
$1.29	-77.7%	+$418.59
$2.57	-55.6%	+$290.68
$3.85	-33.6%	+$162.77
$5.13	-11.5%	+$34.86
$6.41	+10.6%	-$52.50
$7.68	+32.7%	-$52.50
$8.96	+54.8%	-$52.50
$10.24	+76.9%	-$52.50
$11.52	+99.0%	-$52.50

When traders use long put on WVE

Long puts on WVE hedge an existing long WVE stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying WVE exposure being hedged.

WVE thesis for this long put

The market-implied 1-standard-deviation range for WVE extends from approximately $0.85 on the downside to $10.73 on the upside. A WVE long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long WVE position with one put per 100 shares held. Current WVE IV rank near 89.48% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on WVE at 297.70%. As a Healthcare name, WVE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to WVE-specific events.

WVE long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. WVE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move WVE alongside the broader basket even when WVE-specific fundamentals are unchanged. Long-premium structures like a long put on WVE are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current WVE chain quotes before placing a trade.

Frequently asked questions

What is a long put on WVE?: A long put on WVE is the long put strategy applied to WVE (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With WVE stock trading near $5.79, the strikes shown on this page are snapped to the nearest listed WVE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are WVE long put max profit and max loss calculated?: Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the WVE long put priced from the end-of-day chain at a 30-day expiry (ATM IV 297.70%), the computed maximum profit is $546.50 per contract and the computed maximum loss is -$52.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a WVE long put?: The breakeven for the WVE long put priced on this page is roughly $5.48 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current WVE market-implied 1-standard-deviation expected move is approximately 85.35%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on WVE?: Long puts on WVE hedge an existing long WVE stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying WVE exposure being hedged.
How does current WVE implied volatility affect this long put?: WVE ATM IV is at 297.70% with IV rank near 89.48%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.